TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/14/2025
Back to search
Official data from USPTO
XAP THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
XAP THERAPEUTICS
ST13
US500000090726980Class
1, 5, 42
Filing
90726980
Registration
6785291
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/19/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
05/21/2021
Registration date
07/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2022
Last transaction
07/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Cambridge, GB
Examiner
BROOKSHIRE,DAVID AARON
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
XAP THERAPEUTICS LIMITED
XAP THERAPEUTICS LIMITED
Rockend Limited
Representatives
PETER SLOANE LEASON ELLIS LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in biotechnological product development
Class 5
Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous systemthe immune systemthe metabolic systemthe musculo-skeletal systemthe cardiovascular systemthe respiratory systeminfectious diseasesobesityincontinencecancerinflammation and inflammatory diseasesauto-immune diseasesblood diseasestumorsmultiple sclerosisulcerative colitisarthritisskin disease
Class 42
Biotechnology research; Pharmaceutical research and development; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
23 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2022
PUBO
PUBLISHED FOR OPPOSITION
04/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2022
ALIE
ASSIGNED TO LIE
03/07/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/02/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/03/2022
GNSL
LETTER OF SUSPENSION E-MAILED
02/03/2022
CNSL
SUSPENSION LETTER WRITTEN
02/03/2022
DOCK
ASSIGNED TO EXAMINER
02/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/04/2021
NWAP
NEW APPLICATION ENTERED
05/25/2021
Continuous trademark protection
Get notified about every new filing that threatens XAP THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.